The Emerging Biotech Leader

Clinical Operations as a Strategic Function


Listen Later

In this episode of Emerging Biotech Leaders, host Ramin Farhood speaks with Meaghan Powers, Senior Director of Clinical Operations at SSI Strategy. With deep experience across biotech, pharma, and consulting, she offers a clear view of where clinical operations drives strategic value and how early engagement can set emerging biotechs up for success. 

Key Themes and Insights 

1. Clinical Operations Is a Strategic Function 
Clinical operations is often misunderstood as a task-driven, execution-only role. In reality, it requires strategic planning early in development, including anticipation of regulatory expectations, operational risks, and study feasibility well before a protocol is finalized. 

2. Early Cross-Functional Input Prevents Downstream Problems 
Strong clinical programs benefit when core scientific, operational, and quality perspectives are brought together early. Aligning these functions at the concept stage helps shape feasible early-phase designs and creates more stability as the program moves into later development. 

3. Sponsors Cannot Outsource Accountability 
Certain operational tasks can be outsourced, but responsibility for the trial remains with the sponsor. Decisions relating to strategy, vendor performance, and data stewardship require sponsor ownership, supported by clear expectations for partners and defined routes for escalation. These elements establish the framework within which a CRO or other vendor operates. 

4. Effective Oversight Systems Reduce Regulatory and Operational Risk 
Even with the right division of responsibilities, oversight must function in practice. Programs need structured processes for reviewing site conduct, monitoring outputs, and data quality to ensure issues surface early. When these checks are weak or inconsistent, avoidable problems can accumulate and lead to inspection findings or broader trial disruptions. 

5. Emerging Leaders Benefit from Staying Curious and Involved 
Leaders are not expected to master clinical operations, but early engagement with clinical operations strengthens decision-making. It gives programs better visibility into resourcing, risk points, and the operational systems required to advance development. 

For a closer look at how these ideas play out in real development settings, listen to the full episode. 

...more
View all episodesView all episodes
Download on the App Store

The Emerging Biotech LeaderBy SSI Strategy

  • 5
  • 5
  • 5
  • 5
  • 5

5

10 ratings


More shows like The Emerging Biotech Leader

View all
Radiolab by WNYC Studios

Radiolab

44,007 Listeners

The Moth by The Moth

The Moth

27,168 Listeners

The McKinsey Podcast by McKinsey & Company

The McKinsey Podcast

379 Listeners

The Daily by The New York Times

The Daily

112,482 Listeners

Up First from NPR by NPR

Up First from NPR

56,742 Listeners

Worklife with Adam Grant by TED

Worklife with Adam Grant

9,162 Listeners

The Readout Loud by STAT

The Readout Loud

323 Listeners

BioCentury This Week by BioCentury

BioCentury This Week

34 Listeners

Biotech Hangout by Daphne Zohar, Josh Schimmer, Brad Loncar, Tim Opler & more

Biotech Hangout

21 Listeners

The Top Line by Fierce Life Sciences

The Top Line

14 Listeners